gastroparesis and glp 1 drugs GLP-1 Gastroparesis: What Patients Should Know? Gastrointestinal effect and adverse effects
Description
NAION occurs when blood flow to the optic disc is blocked, causing swelling which could lead to vision loss
Tirzepatides May 13, 2022 approval as Mounjaro for type 2 diabetes introduced the first dual GIP/GLP 1 receptor agonist, producing unprecedented weight loss
Additionally, GLP-1 agonists suppress glucagon secretion from pancreatic alpha cells, slow gastric emptying, and promote satiety through central nervous system effects, contributing to weight loss in many patients
Mechanism of action Insulin glargine (Toujeo) works by directly providing exogenous insulin to the body
What is the Best GLP-1 for Weight Loss
Further studies are warranted to assess the exact site of absorption and the optimal dosage for the desired action with tolerable adverse effects
